Celsion sheds BPH microwave system
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific picks up Celsion's Prolieve microwave urethroplasty system for $60 million, Celsion announces April 18. Boston Scientific will pay $30 million at the close of the deal and two annual installments of $15 million. Boston Scientific began selling the Prolieve benign prostate hyperplasia treatment system in 2004 under a distribution agreement that had been set to expire in 2009 (1"The Gray Sheet" Feb. 23, 2004, p. 23). The sale of Prolieve completes Celsion's transition to an oncology focused drug company...